Meyahealth
HomeGeneticsConditionLAMA2-related muscular dystrophy
Back to Condition
LAMA2-related muscular dystrophy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

LAMA2-related muscular dystrophy

LAMA2-related muscular dystrophy is a congenital muscle disorder ranging from severe, early-onset weakness to milder, late-onset forms caused by mutations in the LAMA2 gene.

Overview

LAMA2-related muscular dystrophy causes weakness of the skeletal muscles. The severity varies significantly, ranging from a severe, early-onset type (sometimes called congenital muscular dystrophy type 1A) to a milder, late-onset form.

Early-Onset Form

Apparent at birth or within the first few months of life, this form is characterized by:

  • Severe muscle weakness and lack of muscle tone (hypotonia)
  • Little spontaneous movement
  • Joint deformities (contractures)
  • Feeding difficulties and failure to thrive due to facial and throat muscle weakness
  • Respiratory insufficiency, leading to a weak cry and potential lung infections
  • Spinal curvature (scoliosis and lordosis)
  • Delayed or absent ability to walk
  • Seizures (in about one-third of individuals)

Late-Onset Form

Symptoms become evident later in childhood or adulthood and resemble limb-girdle muscular dystrophies. The muscles closest to the body (proximal muscles)—specifically the shoulders, upper arms, pelvic area, and thighs—are most affected. While motor skill development may be delayed, affected individuals generally achieve the ability to walk, though they may later develop joint contractures, scoliosis, and breathing problems.

Causes

The disorder is caused by mutations in the LAMA2 gene, which provides instructions for the alpha-2 subunit of laminin proteins (specifically laminin 2 and laminin 4). These proteins are found in the extracellular matrix and are essential for maintaining the stability of muscle fibers. Mutations result in a deficiency or absence of these proteins, reducing muscle tissue strength and stability.

Inheritance

This condition is inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations. Parents of an affected individual each carry one copy of the mutated gene but typically do not exhibit symptoms.

Frequently Asked Questions

Respiratory insufficiency is a major concern, particularly in the early-onset form. Weakness in the muscles that control breathing can lead to shallow breaths, a weak cry, and an increased risk of pneumonia. Over time, this can progress to chronic respiratory failure. Families and clinicians must monitor for signs of poor lung clearance, such as frequent chest infections or difficulty clearing mucus. Early intervention with respiratory support, such as non-invasive ventilation or cough-assist devices, is often necessary to prevent life-threatening complications and maintain quality of life.
Management focuses on maintaining mobility, preventing complications, and supporting respiratory function. Physical and occupational therapy are essential to stretch muscles, prevent or delay joint contractures, and maintain range of motion. Orthotics or braces may be used to support the spine and limbs. For those with the late-onset form, the goal is to preserve independence for as long as possible. For the early-onset form, care is often multidisciplinary, involving neurologists, pulmonologists, and geneticists to manage seizures, feeding difficulties, and respiratory support. Regular monitoring of spine curvature (scoliosis) is also critical, as it can further compromise lung function.
The severity of this condition exists on a spectrum. The early-onset form, often called congenital muscular dystrophy type 1A, is apparent at birth or within the first few months. It is characterized by severe weakness, low muscle tone, joint contractures, and significant respiratory issues that can lead to lung infections. Many individuals with this severe form never walk independently. In contrast, the late-onset form presents later in childhood or adulthood. While it still causes weakness in the shoulders, hips, and thighs, individuals usually achieve the ability to walk, though they may later develop scoliosis and breathing difficulties.
Diagnosis is typically confirmed through genetic testing that identifies mutations in the LAMA2 gene. Since the condition is inherited in an autosomal recessive pattern, both parents must be carriers of a mutated copy of the gene. This means that each pregnancy has a 25 percent chance of being affected, a 50 percent chance of the child being an unaffected carrier, and a 25 percent chance of the child being neither affected nor a carrier. Genetic counseling is strongly recommended for parents to understand these risks and to discuss options for prenatal or preimplantation genetic testing in future pregnancies.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ